In new guidelines published Monday, the American Academy of Pediatrics renewed their call for 11- and 12-year-old boys to get the three-dose vaccine for the human papillomavirus (HPV).
New research suggests men could have an increased risk of head and neck cancers because, when compared to women, men tend to have the oral human papillomavirus (HPV) in greater numbers.